Compared to healthy controls, in NAFLD patients, miR-21 was upregulated by about 2-fold and LncRNA NEAT1 by 2.9-fold, whereas miR-197 and lncRNA MEG3 were downregulated by 0.25- and 0.41-fold, respectively. This evidence concerns the gene MEG3 and metabolic dysfunction-associated steatotic liver disease.